eNOS polymorphisms as predictors of efficacy of bevacizumab-based chemotherapy in metastatic colorectal cancer: data from a randomized clinical trial
Crossref DOI link: https://doi.org/10.1186/s12967-015-0619-5
Published Online: 2015-08-11
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ulivi, Paola
Scarpi, Emanuela
Passardi, Alessandro
Marisi, Giorgia
Calistri, Daniele
Zoli, Wainer
Del Re, Marzia
Frassineti, Giovanni Luca
Tassinari, Davide
Tamberi, Stefano
Vertogen, Bernadette
Amadori, Dino